Every experience leaves a trace in the brain, a memory that can shape future behavior. Alcohol and other addictive substances ...
Tyler Lawrence tells PEOPLE about his recovery as a quadriplegic, getting sober and his new chapter as a content creator ...
The experimental drug fenebrutinib worked better than Aubagio, an approved therapy, for reducing relapse rates in MS, new ...
Every experience leaves a trace in the brain, a memory that can shape future behavior. Alcohol and other addictive substances ...
A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.
For decades, prevailing wisdom held that to overcome addiction, the most important thing to do was to flush or “clean” the drugs out of one’s system, to get a fresh start. But more and more, research ...
Treatment with satralizumab reduced the risk of new MOGAD relapse by 68% vs placebo. Positive results were announced from a phase 3 trial evaluating satralizumab for the treatment of myelin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results